DHSC gives go ahead for boys to receive HPV vaccine

DHSC gives go ahead for boys to receive HPV vaccine

July 27 2018 Adolescent boys will be offered the human papilloma virus (HPV) vaccine to protect...

Home Office gives go ahead to allow cannabis-derived products on prescription

Home Office gives go ahead to allow cannabis-derived products on prescription

July 27 2018 Certain cannabis-derived products will be reclassified as Class 2 medicinal...

New law strengthens punishment for assaulting health sector workers

New law strengthens punishment for assaulting health sector workers

July 27 2018 A new law will increase the possible sentencing of someone who commits common...

Asthma deaths levels increase by a quarter in a decade

Asthma deaths levels increase by a quarter in a decade

July 26 2018 There were 1,320 deaths due to asthma in England and Wales in 2017, the highest...

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

July 24 2018 New Health Secretary Matt Hancock has called for investment in primary care and...

  • DHSC gives go ahead for boys to receive HPV vaccine

    DHSC gives go ahead for boys to receive HPV vaccine

    Friday, 27 July 2018 16:22
  • Home Office gives go ahead to allow cannabis-derived products on prescription

    Home Office gives go ahead to allow cannabis-derived products on prescription

    Friday, 27 July 2018 16:19
  • New law strengthens punishment for assaulting health sector workers

    New law strengthens punishment for assaulting health sector workers

    Friday, 27 July 2018 16:16
  • Asthma deaths levels increase by a quarter in a decade

    Asthma deaths levels increase by a quarter in a decade

    Thursday, 26 July 2018 15:29
  • Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Tuesday, 24 July 2018 13:07

A Resized Recall Image cb1March 6 2018

Zinbryta (daclizumab) is being withdrawn from the market following new concerns about the drug’s side effects. The drug, used by people with multiple sclerosis, is being withdrawn worldwide on a voluntary basis by its manufacturers. 

On Friday, the European Medicines Agency announced that it had started an urgent review of the drug following seven cases of serious inflammatory brain disorders in Germany, including encephalitis and meningoencephalitis, and one case in Spain.

In 2017, following a review of the medicine’s effects on the liver, the EMA had restricted the drug’s use to patients who had tried at least two other disease-modifying treatments and could not be treated with any other MS treatments.

Announcing the review into the effect on brain disorders, the EMA said that “the company that markets Zinbryta (Biogen Idec Ltd) has informed EMA of its intention to voluntarily withdraw the medicine’s marketing authorisations.” Zynbryta is also marketed elsewhere in the world by AbbVie.

Advice issued by the EMA includes:

  • doctors should not start new patients on Zinbryta;
  • doctors should review patients currently treated with Zinbryta and initiate alternative therapy, as soon as possible;
  • patients must not stop their medication without discussing with their doctor;
  • patients who have any questions should talk to their doctor.

The EMA will be contacting EU doctors directly with the information. As Biogen has also informed the EMA of its decision to stop ongoing clinical studies with Zinbryta in the EU, “patients in clinical studies who have any question should contact the doctor treating them in their study.”

Over 8,000 patients worldwide have been treated with Zinbryta. In the EU, the majority of patients are in Germany.

Link:
EMA announcement    

Professional News

July 27 2018 Adolescent boys will be offered the human papilloma virus (HPV) vaccine to protect them from cancer, the Department of Health and Social Care has announced.
July 20 2018 Doctors are being reminded to ensure that any patient or other records which may be relevant to the UK Infected Blood Inquiry are not destroyed. Earlier this month, the Inquiry’s Chair, Sir...